A steamy shipping glitch has forced Novartis’ generics unit to yank a batch of deep vein thrombosis meds from U.S. shelves. Sandoz is recalling one
Author: TNN Correspondent
Bayer pads blockbuster case for Nubeqa with phase 3 win in metastatic prostate cancer
Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result in the drug reaching more
Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; Fujifilm’s U.K. investment
Novo Nordisk, Sanofi and Eli Lilly offered big discounts for their insulin products in China. Astellas partnered with Dyno Therapeutics on viral vectors for gene
AstraZeneca blocks investor group’s $7.6B buyout of rare disease specialist Sobi: report
After its $39 billion takeover of Alexion, AstraZeneca has reportedly scuppered an investor group’s proposed buyout of another rare disease drugmaker. The company was worried
Biogen’s Spinraza, Fosun-Kite’s Yescarta and a controversial Alzheimer’s drug: All you need to know about China’s new state coverage
It’s that time of year again when biopharma companies cut the price of their drugs to win national coverage in China. Sixty-seven novel therapies entered
NIHR study shows high efficacy of booster vaccines
The news arrives after the tenth recorded positive Omicron case in Scotland, which the government has confirmed has no previous connection to the previous nine.
GSK to provide malaria vaccines for Gavi eligible countries
The new development will arm healthcare providers with a vital tool to address the steep rise of malaria cases in children living in Africa. GlaxoSmithKline
Amgen’s Otezla notches win in genital psoriasis, snagging possible edge against forthcoming BMS rival
With a potential Bristol Myers rival looming on the horizon, Amgen’s inflammatory disease med Otezla is hustling to cement its position in psoriasis. Now, the
Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa
History is repeating for Aspen Pharmacare. Nearly 20 years ago, as Africa grappled with an HIV epidemic, Aspen pioneered the first generic antiretroviral on the
Thermo Fisher Scientific’s TaqPath COVID-19 Tests can detect the presence of the Omicron variant in SARS-CoV-2 samples
Thermo Fisher Scientific, the world leader in serving science confirmed that its TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit can accurately detect the presence of the